Gibson Dunn Scores for Allergan in Eyelash Enhancer Feud

, The Litigation Daily

   |0 Comments

The Federal Circuit rejected a rival's defense that Allergan's RevitaLash product is a cosmetic and not a drug.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202635355816

Thank you!

This article's comments will be reviewed.